Pilot Study of an Educational Tool for Chronic Obstructive Pulmonary Disease (PUDDING)
The inadequate fulfillment of national targets for COPD described above indicates that interventions designed to increase adherence to recommendations in established guidelines could improve patient outcomes. This pilot study is therefore intended to indicate if a digital educational tool can increase adherence to COPD guidelines and measurably improve measures of disease control. If the objectives of the study are met, it provides a rationale for further developing the tool and validating it in controlled studies. This is an 8-week, single-arm pilot study in patients with COPD. A total of 35 patients will be included. Based on an anticipated screening failure rate of 50%, 70 patients will be screened. Patients will receive standard of care with a board-certified physician using an educational COPD tool.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Höllviken, Sverige, 23651
- Näsets läkargrupp, Prima Vård AB
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- COPD diagnosed at least 6 months prior to inclusion
- mMRC score of 2 or more at screening visit
Exclusion Criteria:
- Previous participation in this study. Participation is defined as informed consent.
- Currently participating in clinical trials for COPD.
- Ongoing oxygen treatment.
- Significant pulmonary disease other than COPD (e.g., asthma, lung fibrosis, sarcoidosis, interstitial lung disease, pulmonary hypertension, bronchiectasis, or Churg-Strauss syndrome, etc.).
- History of or planned pneumonectomy or lung volume reduction surgery.
- Patients participating in the acute phase of a pulmonary rehabilitation program, i.e., who started rehabilitation < 4 weeks prior to screening.
- Diagnosis of α-1 anti-trypsin deficiency.
- Ongoing treatment with oral corticosteroids for any indication.
- Treatment with systemic medication for COPD such as oral corticosteroids or monoclonal antibodies in the 28 days prior to screening.
- Heart failure NYHA Class III or IV.
- Acute myocardial infarction < 6 months from screening visit.
- TIA or stroke < 6 months from screening visit.
- Hospitalization for any CV or cerebrovascular event < 6 months from screening visit.
- Ongoing treatment for cancer.
- Other conditions that by the investigator's judgment cause remaining life expectancy to be less than a year.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Intervention - treatment guided by digital tool
Intervention guided by the digital tool |
The intervention is that the treating physician will be guided by a digital tool describing treatment recommendations for COPD. The choice of treatment will be made by the investigator, based on his or her clinical judgment supplemented with support from the educational tool. All participating patients in the study will be treated by a physician that uses the tool. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
CAT score
Tidsramme: 8 weeks
|
Change in COPD assessment test (CAT) score |
8 weeks
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
mMRC
Tidsramme: 8 weeks
|
Change in mMRC (modified medical research council) score |
8 weeks
|
|
Walking distance
Tidsramme: 8 weeks
|
Change in walking distance on a 6 minute walk test |
8 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 2026-01001-02
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .